ANVMX | TRWTX | ANVMX / TRWTX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 5 years | 32 years | - |
Gain YTD | 0.106 | 4.128 | 3% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 559M | 4.32B | 13% |
Annual Yield % from dividends | 2.99 | 3.11 | 96% |
Returns for 1 year | -0.34 | 13.09 | -3% |
Returns for 3 years | -3.17 | 2.86 | -111% |
Returns for 5 years | N/A | 27.56 | - |
Returns for 10 years | N/A | 39.20 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SMLKX | 23.65 | -0.22 | -0.92% |
Shelton S&P Smallcap Index K | |||
QUERX | 25.70 | -0.33 | -1.27% |
AQR Large Cap Defensive Style R6 | |||
SUHIX | 44.85 | -0.97 | -2.12% |
DWS Health and Wellness Inst | |||
AGWUX | 61.35 | -1.41 | -2.25% |
American Century Growth R5 | |||
FBDIX | 136.77 | -6.82 | -4.75% |
Franklin Biotechnology Discovery A |